HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ristocetin A

ristocetin A & B forms differentiated by paper chromatography; RN given refers to parent cpd; see also ristocetin: 1404-55-3

Also Known As:

ristocetin B; ristomycin A; ristomycin B

Networked: 6 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Ristocetin: 319
      - ristocetin A: 6
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Ristocetin: 319
      - ristocetin A: 6

Experts

1.	Borst, Oliver: 1 article (10/2014)
2.	Gross, Harald: 1 article (10/2014)
3.	Jochim, Angelika: 1 article (10/2014)
4.	Kirchner, Norbert: 1 article (10/2014)
5.	Kulik, Andreas: 1 article (10/2014)
6.	Muenzer, Patrick: 1 article (10/2014)
7.	Spohn, Marius: 1 article (10/2014)
8.	Stegmann, Evi: 1 article (10/2014)
9.	Wohlleben, Wolfgang: 1 article (10/2014)
10.	Wolf, Felix: 1 article (10/2014)

Related Diseases

1.	Inborn Genetic Diseases (Disease, Hereditary) 01/01/2023 - "In order to demonstrate that this metabolic engineering approach is generally applicable to GPA producers, we subsequently applied this strategy to Amycolatopsis japonicum and improved the production of ristomycin A, which is used in diagnosis of genetic disorders. "
2.	von Willebrand Diseases (von Willebrand's Disease) 05/01/1973 - "Ristocetin: a means of differentiating von Willebrand's disease into two groups." 10/01/2014 - "ristocetin), a type III glycopeptide, which has antibacterial activity and which is used for the diagnosis of von Willebrand disease and Bernard-Soulier syndrome, was deduced as a possible product of the gene cluster. " 08/01/2009 - "Ristocetin A is a class III glycopeptide antibiotic that is used in the diagnosis of von Willebrand disease and which has served as a lead compound for the development of new antimicrobial therapeutics. "
3.	Type 2 von Willebrand Disease 01/01/2013 - "An increased aggregation response to low-dose ristocetin (a type IIb von Willebrand disease-like defect) is associated with thrombus formation. "
4.	Thrombosis (Thrombus) 01/01/2013 - "An increased aggregation response to low-dose ristocetin (a type IIb von Willebrand disease-like defect) is associated with thrombus formation. "
5.	Respiratory Tract Infections (Respiratory Tract Infection) 01/01/1959 - "Clinical observations on ristocetin; a preliminary report of its efficacy and toxicity in 20 unselected severe respiratory infections."

Related Drugs and Biologics

1.	Glycopeptides
2.	Anti-Bacterial Agents (Antibiotics)

Related Therapies and Procedures

1.	Therapeutics